Skip to main content

Table 1 Descriptive statistics of study cohort followed from 6–24 months of age

From: Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children

Characteristic No chemoprevention Monthly DHA/PQ
Number of children followed 89 87
Female gender, n (%) 41 (46) 46 (54)
Location of residence, n (%)
 Rural, n (%) 85 (95.5) 79 (90.8)
 Town, n (%) 2 (2.3) 6 (6.9)
 Unknown, n (%) 2 (2.3) 2 (2.3)
Maternal age in years
 16 to <22, n (%) 30 (33.7) 25 (28.7)
 22 to <36, n (%) 53 (59.6) 53 (60.9)
 36 to <45, n (%) 6 (6.7) 9 (10.3)
House construction
 Non-ideal home 81 (91.0) 75 (86.2)
 Ideal home 6 (6.7) 10 (11.5)
 Unknown 2 (2.3) 2 (2.3)
Primary caregiver education
 Primary school or less, n (%) 69 (77.5) 74 (85.1)
 More than primary school, n (%) 18 (20.2) 11 (62.5)
 Unknown, n (%) 2 (2.3) 2 (2.3)
  1. DHA/PQ dihydroartemisinin-piperaquine